Skip to main content

Carolina E.K. Säve

Of Counsel

[email protected]



Carolina focuses her practice on the protection of client innovations in the mechanical, electrical, and computer science arts, including technologies involving artificial intelligence (AI). Leveraging her experience as an in-house counsel and registered patent attorney, Carolina aids with patent preparation and prosecution, strategic portfolio development, freedom to operate analysis, licensing, and diligence for companies with cutting-edge technologies. She represents clients across the technology, life sciences, medical devices, and automotive industries.

Prior to rejoining Mintz, Carolina was the director of intellectual property at a Massachusetts-based medical robotics company. In that role, she partnered with the company’s executive team to develop and manage an IP strategy aligned with the company’s business goals. Working in collaboration with the company’s R&D team, she also built and managed a US and international patent portfolio focused on the surgical robotics field that included mechanical, electrical, software, and AI-related technologies.

In addition to her IP experience with a company in the medical robotics field, where Carolina worked on patent matters involving a range of medical technology, including surgical instruments, network communications, and innovations using artificial intelligence (AI), she has significant experience in the automotive industry. Carolina regularly aids clients in obtaining patent protections for their cutting-edge advancements in autonomous vehicles, fuel cells, environmentally friendly technologies, driver-assist technologies, battery systems, and transmissions. 

Earlier in her career, Carolina was an associate at another international law firm. She also previously worked as a patent agent at an intellectual property boutique firm in Boston, where she concentrated on the patent prosecution of a variety of technologies, including consumer products, mechanical technologies, and electrical devices.


  • US and international prosecution
  • Application drafting
  • IP due diligence
  • Trademark
  • Portfolio management
  • Opinions: patentability, freedom to operate, validity, and infringement
Read less


As 2021 begins and intellectual property (IP) strategies are being developed for the new year, it is a good time to reflect on what IP issues were prominent in 2020.  According to many readers, hot topics included Chinese foreign filing licenses, patenting involving either artificial intelligence (AI) or COVID-19, inter partes review, and attorney fee awards.
Read more
On June 16, 2020, the U.S. Patent and Trademark Office (USPTO) released final rules (the “Rules”) implementing changes to how Patent Term Adjustment (PTA) is calculated in certain circumstances in view of Supernus Pharms., Inc. v. Iancu, 913 F.3d 1351 (Fed. Cir. 2019). 
Read more
The United States Patent and Trademark Office (USPTO) has recently launched two new initiatives to support COVID-19 innovations: 1) a COVID-19 Prioritized Examination Pilot Program, and 2) Patents 4 Partnerships that provides a searchable forum to list COVID-19 related published applications and patents available for licensing.
Read more
Read less

Events & Speaking

Event Reference Image
Read less

Recognition & Awards

  • Managing Intellectual Property: Rising Star (2018 – 2019, 2021 – 2022)

Read less


  • Co-Chair, Patent Law Committee, Boston Bar Association (2021 – present)
  • Co-Chair, Business & Marketplace Committee, Boston Intellectual Property Law Association (2022 – present)
  • Board Member, Esplanade Association (2017 – present)
  • Board Member, The North American Station (2015 – present)
  • Former Co-Chair, IP Year in Review Committee, Boston Bar Association (2019 – 2021)
  • Former Co-Chair, Moot Court Committee, Boston Patent Law Association (2017 – 2022)
  • Former Chair, Governance & Nominating Committee, Esplanade Association
Read less